BACKGROUND:

To assess the overlap and admission or transfer rate of children with chronic complex conditions (CCC) and with mental or behavioral health (MBH) disorders among children presenting to the emergency department (ED).

METHODS:

We performed a cross-sectional analysis from 2 data sources: hospitals in the Pediatric Health Information System (PHIS) and from a statewide sample (Illinois COMPdata). We included ED encounters 2 to 21 years and compared differences in admission and/or transfer between subgroups. Among patients with both a CCC and MBH, we evaluated if a primary MBH diagnosis was associated with admission or transfer.

RESULTS:

There were 11 880 930 encounters in the PHIS dataset; 0.7% had an MBH and CCC, 2.2% had an MBH, and 8.0% had a CCC. Patients with an MBH and CCC had a greater need for admission or transfer (86.5%) compared with patients with an MBH alone (57.7%) or CCC alone (52.0%). Among 5 362 701 patients in the COMPdata set, 0.2% had an MBH and CCC, 2.1% had an MBH, and 3.2% had a CCC, with similar admission or transfer needs between groups (61.8% admission or transfer with CCC and MBH; 42.8% MBH alone, and 27.3% with CCC alone). Within both datasets, patients with both a MBH and CCC had a higher odds of admission or transfer when their primary diagnosis was an MBH disorder.

CONCLUSIONS:

While accounting for a small proportion of ED patients, CCC with concomitant MBH have a higher need for admission or transfer relative to other patients.

The utilization of the emergency department (ED) for mental or behavioral health emergencies (MBH) continues to rise. This trend began before the coronavirus disease 2019 pandemic,1  with evidence suggesting that the pandemic further accelerated these changes.24  ED encounters for suicidality have nearly doubled over the past decade.5  Concomitant with this is a separate trend in increased utilization of ED resources by children with medical complexity.6  Children with medical complexity have a variety of needs placing them at higher risk of admission, critical illness, readmissions, and mortality.710  These children are medically fragile and have health care needs that are poorly met by existing care models.1114 

In a national research agenda for children with medical complexity, a key topic was the need for better clinical-model refinement for children with varied health care needs, including interventions that improve outcomes for children with MBH disorders.15  Children with medical complexity may be at higher risk of MBH. A study from the National Health Interview Survey Disability Supplements identified that 14% of children with disabilities had recently received mental health services.16  However, among medically complex children with poor psychosocial adjustment, nearly 60% had not received recent mental health services.16 

An improved understanding of the complexity or comorbidity of children with MBH conditions in the ED will allow EDs to better prepare for and address this growing need. We aimed to characterize the extent of overlap and need for admission and/or transfer among children with medical complexity and those with developmental and mental health disorders in the ED.

We performed a multicenter cross-sectional study using 2 data sources to evaluate the medical needs and overlap of patients with MBH disorders and those with medical complexity and to study the association between a MBH diagnosis and an outcome of admission or transfer.

  1. First, we used the Pediatric Health Information System (PHIS) dataset, an administrative database coordinated by the Children’s Hospital Association (Lenexa, Kansas). We included data from 45 PHIS hospitals that contributed ED data continuously during the study period.

  2. Second, we used the COMPdata dataset, an administrative database of inpatient discharge and outpatient records maintained by the Illinois Health and Hospital Association. COMPdata provides encounter-level data from participating community, tertiary care, and academic hospitals, encompassing approximately 90% of nonfederal hospitals within the state.17 

Although PHIS allows for a detailed evaluation of resource utilization with patients with complex chronic conditions (CCC) using a generalizable sample of children’s hospitals, COMPdata allows for an evaluation of statewide data to nonpediatric facilities, which represent where most children obtain acute care in the United States.18  This study was approved by the Institutional Review Board at (place redacted for review). From each dataset, we included patients ≥2 and <21 years of age and with an ED encounter for the years 2016 to 2021. We did not include patients <2 years of age given the that these patients were much more likely to have diagnoses related to developmental delay, which would make comparisons with the typical MBH diagnoses more difficult to interpret.

We used the CCC algorithm, which assigns patients into categories of chronic disease based on procedure and diagnosis codes, but which does not provide a dedicated grouping for patients with MBH disorders at the encounter level. We used the latest version of the CCC system, which uses International Classification of Disease, 10th revision (ICD-10) diagnosis codes.19  We elected to use the CCC as it is a widely used method to identify patients with medical complexity in the ED setting for a variety of health services research and as it can be applied at the encounter level, but which does not have a dedicated subgrouping for MBH disorders, allowing for the identification of overlapping groups. This contrasts with other grouping systems for medical complexity, such as the Pediatric Medical Complexity Algorithm which does have mental health diagnoses in the algorithm.20 

To identify patients with MBH conditions, we used a rubric for these diagnoses using the Child and Adolescent Mental Health Disorders Classification System, which utilizes the International Classification of Diseases Tenth Revision, Clinical Modification diagnoses to classify child mental health disorders into 21 child mental disease categories and aligns with The Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition diagnosis groups.21 

We identified 4 mutually exclusive subgroups: (1) patients with CCC without a MBH, (2) patients with a MBH disorder without a CCC, (3) patients with both a CCC and MBH disorder, and (4) patients with neither a MBH disorder nor CCC.

For patients with a CCC, we identified the number and types of CCCs present. Age was classified into groups of 2–5 years, 6–11 years, 12–18, and 19–21 years.22  We included the social constructs of race and ethnicity as identified in administrative data given recognized disparities based on these variables23,24  but did not incorporate this variable in multivariable modeling. Payor type was classified based on the presence of private insurance, public insurance, and other (which included categories of charitable, self-pay, and unknown). Length of stay was recorded in days. We evaluated costs from individual components of patient care and the performance of neuroimaging or laboratory testing. From PHIS, we acquired data with respect to medication use, including use of any medication, use of a psychotropic medication, and use of an intravenous medication and data with respect to subsequent hospital utilization, including inpatient hospitalization, ICU hospitalization, 1-year mortality, and aggregated standardized costs.

Our primary outcome of interest was a composite outcome of admission and/or transfer. This was done because some hospitals admit first to a medical bed and then transfer to a psychiatric bed, particularly in situations of capacity limits or if medical clearance is needed before psychiatric admission.

We evaluated the overlap between patients with CCC and MBH disorders. Among patients with MBH and a CCC, we characterized the type and number of CCCs. We evaluated counts of patients with CCC, MBH, and both CCC and MBH by fiscal quarter. We describe demographics and ED disposition by subgroup. We identified if a primary discharge diagnosis of an MBH was independently associated with a composite outcome of admission or transfer to another institution using a multivariable linear mixed model adjusting for number of CCCs, age, year of presentation, and payor status. We used the age group of 12 to 18 years as the reference group for age as this was the largest category. We present results as odds ratios with 95% confidence intervals (CI). Analyses were performed in R, version 4.1.1 (R Foundation for Statistical Computing, Vienna, Austria).

To further evaluate the role of specific MBH disorders on an outcome of admission or transfer among patients, we constructed an additional model for each dataset wherein we identified the type of MBH listed in the principal diagnosis (again keeping no MBH primary diagnosis as the reference group) and in which we adjusted for individual types of CCC. We grouped the granular Child and Adolescent Mental Health Disorders Classification System groupings into 11 larger groupings described by the Clinical Classifications Software.21 

To evaluate longitudinal resource utilization related to patients with a concomitant MBH or CCC and compare it to children with only a single or neither disorder, we modified our PHIS inclusion criteria to be limited to the first encounter per patient from the years 2016 to 2020 and reported the following longitudinal outcomes within 365 days of their index discharge: ED encounters, admissions, and admissions requiring the ICU and cost. We performed our logistic regression model limited only to these unique patients.

For both datasets, inclusion is provided in Supplemental Fig 2 and demographics are provided in Table 1. Characteristics of CCCs and MBH disorders among patients with both conditions are provided in Table 2. Outcomes are provided in Table 3. Results of logistic regression modeling are provided in Supplemental Table 4 and 5.

TABLE 1

Patient Subgroups Derived From the Pediatric Health Information System (PHIS) and Illinois COMPdata Datasets

VariableBoth CCC and MBH, n (%)MBH Disorder Without CCC, n (%)CCC Without MBH Disorder, n (%)Neither CCC nor MBH Disorder, n (%)Overall, n (%)
PHIS 
N 80 452 255 714 945 194 10 599 570 11 880 930 
 Age      
  2 to 5 y 8117 (10.1) 9608 (3.8) 283 527 (30.0) 4 020 693 (37.9) 4 321 945 (36.4) 
  6 to 11 y 18 046 (22.4) 58 434 (22.9) 269 916 (28.6) 3 458 759 (32.6) 3 805 155 (32.0) 
  12 to 18 y 47 794 (59.4) 182 891 (71.5) 340 077 (36.0) 2 955 246 (27.9) 3 526 008 (29.7) 
  19 to <21 y 6495 (8.1) 4781 (1.9) 51 674 (5.5) 164 872 (1.6) 227 822 (1.9) 
 Male sex 38 720 (48.1) 113 522 (44.4) 498 788 (52.8) 5 453 557 (51.5) 6 104 587 (51.4) 
 Race and ethnicity      
  Non-Hispanic white 44 108 (54.8) 140 352 (54.9) 380 711 (40.3) 3 561 608 (33.6) 4 126 779 (34.7) 
  Non-Hispanic Black 14 235 (17.7) 44 612 (17.4) 241 424 (25.5) 2 639 379 (24.9) 2 939 650 (24.7) 
  Hispanic or Latino 14 059 (17.5) 38 605 (15.1) 210 856 (22.3) 3 117 462 (29.4) 3 380 982 (28.5) 
  All others 7064 (8.8) 28 040 (11.0) 99 308 (10.5) 1 070 501 (10.1) 1 204 913 (10.1) 
  Missing 986 (1.2) 4105 (1.6) 12 895 (1.4) 210 620 (2.0) 228 606 (1.9) 
 Primary payor type      
  Private 30 749 (38.2) 102 371 (40.0) 323 705 (34.2) 3 192 055 (30.1) 3 648 880 (30.7) 
  Public 46 899 (58.3) 142 293 (55.6) 575 262 (60.9) 6 570 792 (62.0) 7 335 246 (61.7) 
  Other 1909 (2.4) 8741 (3.4) 32 325 (3.4) 675 209 (6.4) 718 184 (6.0) 
  Unknown 895 (1.1) 2309 (0.9) 13 902 (1.5) 161 514 (1.5) 178 620 (1.5) 
COMPdata  
 Number 11 724 111 950 172 530 5 066 497 5 362 701 
 Age      
  2 to 5 y 429 (3.7) 974 (0.9) 30 887 (17.9) 1 286 128 (25.4) 1 318 418 (24.6) 
  6 to 11 y 971 (8.3) 9983 (8.9) 33 880 (19.6) 1 240 956 (24.5) 1 285 790 (24.0) 
  12 to 18 y 6418 (54.7) 70 861 (63.3) 70 628 (40.9) 1 791 981 (35.4) 1 939 888 (36.2) 
  19 to 21 y 3906 (33.3) 30 132 (26.9) 37 135 (21.5) 747 432 (14.8) 818 605 (15.3) 
 Male Sex 5085 (43.4) 45 688 (40.8) 85 149 (49.4) 2 426 317 (47.9) 2 562 239 (47.8) 
 Race and ethnicity      
  Non-Hispanic white 6813 (58.1) 70 411 (62.9) 70 015 (40.6) 2 128 286 (42.0) 2 275 525 (42.4) 
  Non-Hispanic Black 2040 (17.4) 17 452 (15.6) 53 074 (30.8) 1 378 598 (27.2) 1 451 164 (27.1) 
  Hispanic or Latino 1806 (15.4) 14 148 (12.6) 35 007 (20.3) 1 077 237 (21.3) 1 128 198 (21.0) 
  All others 1002 (8.5) 9395 (8.4) 13 790 (8.0) 464 546 (9.2) 488 733 (9.1) 
  Missing 63 (0.5) 544 (0.5) 644 (0.4) 17 830 (0.4) 19 081 (0.4) 
 Primary payor type      
  Private 5133 (43.8) 49 011 (43.8) 63 909 (37.0) 1 639 725 (32.4) 1 757 778 (32.8) 
  Public 5936 (50.6) 54 884 (49.0) 96 947 (56.2) 2 870 272 (56.7) 3 028 039 (56.5) 
  Other 624 (5.3) 7731 (6.9) 11 028 (6.4) 515 078 (10.2) 534 461 (10.0) 
  Unknown 31 (0.3) 324 (0.3) 646 (0.4) 41 422 (0.8) 42 423 (0.8) 
VariableBoth CCC and MBH, n (%)MBH Disorder Without CCC, n (%)CCC Without MBH Disorder, n (%)Neither CCC nor MBH Disorder, n (%)Overall, n (%)
PHIS 
N 80 452 255 714 945 194 10 599 570 11 880 930 
 Age      
  2 to 5 y 8117 (10.1) 9608 (3.8) 283 527 (30.0) 4 020 693 (37.9) 4 321 945 (36.4) 
  6 to 11 y 18 046 (22.4) 58 434 (22.9) 269 916 (28.6) 3 458 759 (32.6) 3 805 155 (32.0) 
  12 to 18 y 47 794 (59.4) 182 891 (71.5) 340 077 (36.0) 2 955 246 (27.9) 3 526 008 (29.7) 
  19 to <21 y 6495 (8.1) 4781 (1.9) 51 674 (5.5) 164 872 (1.6) 227 822 (1.9) 
 Male sex 38 720 (48.1) 113 522 (44.4) 498 788 (52.8) 5 453 557 (51.5) 6 104 587 (51.4) 
 Race and ethnicity      
  Non-Hispanic white 44 108 (54.8) 140 352 (54.9) 380 711 (40.3) 3 561 608 (33.6) 4 126 779 (34.7) 
  Non-Hispanic Black 14 235 (17.7) 44 612 (17.4) 241 424 (25.5) 2 639 379 (24.9) 2 939 650 (24.7) 
  Hispanic or Latino 14 059 (17.5) 38 605 (15.1) 210 856 (22.3) 3 117 462 (29.4) 3 380 982 (28.5) 
  All others 7064 (8.8) 28 040 (11.0) 99 308 (10.5) 1 070 501 (10.1) 1 204 913 (10.1) 
  Missing 986 (1.2) 4105 (1.6) 12 895 (1.4) 210 620 (2.0) 228 606 (1.9) 
 Primary payor type      
  Private 30 749 (38.2) 102 371 (40.0) 323 705 (34.2) 3 192 055 (30.1) 3 648 880 (30.7) 
  Public 46 899 (58.3) 142 293 (55.6) 575 262 (60.9) 6 570 792 (62.0) 7 335 246 (61.7) 
  Other 1909 (2.4) 8741 (3.4) 32 325 (3.4) 675 209 (6.4) 718 184 (6.0) 
  Unknown 895 (1.1) 2309 (0.9) 13 902 (1.5) 161 514 (1.5) 178 620 (1.5) 
COMPdata  
 Number 11 724 111 950 172 530 5 066 497 5 362 701 
 Age      
  2 to 5 y 429 (3.7) 974 (0.9) 30 887 (17.9) 1 286 128 (25.4) 1 318 418 (24.6) 
  6 to 11 y 971 (8.3) 9983 (8.9) 33 880 (19.6) 1 240 956 (24.5) 1 285 790 (24.0) 
  12 to 18 y 6418 (54.7) 70 861 (63.3) 70 628 (40.9) 1 791 981 (35.4) 1 939 888 (36.2) 
  19 to 21 y 3906 (33.3) 30 132 (26.9) 37 135 (21.5) 747 432 (14.8) 818 605 (15.3) 
 Male Sex 5085 (43.4) 45 688 (40.8) 85 149 (49.4) 2 426 317 (47.9) 2 562 239 (47.8) 
 Race and ethnicity      
  Non-Hispanic white 6813 (58.1) 70 411 (62.9) 70 015 (40.6) 2 128 286 (42.0) 2 275 525 (42.4) 
  Non-Hispanic Black 2040 (17.4) 17 452 (15.6) 53 074 (30.8) 1 378 598 (27.2) 1 451 164 (27.1) 
  Hispanic or Latino 1806 (15.4) 14 148 (12.6) 35 007 (20.3) 1 077 237 (21.3) 1 128 198 (21.0) 
  All others 1002 (8.5) 9395 (8.4) 13 790 (8.0) 464 546 (9.2) 488 733 (9.1) 
  Missing 63 (0.5) 544 (0.5) 644 (0.4) 17 830 (0.4) 19 081 (0.4) 
 Primary payor type      
  Private 5133 (43.8) 49 011 (43.8) 63 909 (37.0) 1 639 725 (32.4) 1 757 778 (32.8) 
  Public 5936 (50.6) 54 884 (49.0) 96 947 (56.2) 2 870 272 (56.7) 3 028 039 (56.5) 
  Other 624 (5.3) 7731 (6.9) 11 028 (6.4) 515 078 (10.2) 534 461 (10.0) 
  Unknown 31 (0.3) 324 (0.3) 646 (0.4) 41 422 (0.8) 42 423 (0.8) 

CCC; complex chronic conditions; MBH, mental and behavioral health. Numbers in parenthesis indicate percents.

TABLE 2

Characteristics of Patients With Overlapping Complex Chronic Conditions (CCC) and Mental and Behavioral Health (MBH) Disorders

VariablePHIS, N (%)COMPdata, N (%)
N 80 452 11 724 
Number of CCC   
 1 42 882 (53.3) 8938 (76.2) 
 2 15 696 (19.5) 1640 (14.0) 
 ≥3 21 874 (27.2) 1146 (9.8) 
Type of CCC   
 Neuromuscular 28 412 (35.3) 2323 (19.8) 
 Tech. dependence 25 157 (31.3) 1572 (13.4) 
 Gastrointestinal 24 606 (30.6) 2304 (19.7) 
 Cardiovascular disease 19 004 (23.6) 2946 (25.1) 
 Metabolic 18 694 (23.2) 3617 (30.9) 
 Congenital or genetic 12 927 (16.1) 1316 (11.2) 
 Hematology or immunology 9875 (12.3) 883 (7.5) 
 Renal 7072 (8.8) 595 (5.1) 
 Respiratory 5315 (6.6) 358 (3.1) 
 Malignancy 5576 (6.9) 460 (3.9) 
 Neonatal 1386 (1.7) 74 (0.6) 
 Transplant 628 (0.8) 37 (0.3) 
MBH disorder   
Anxiety disorder 34 172 (42.5) 7006 (59.8) 
Depressive disorders 28 083 (34.9) 6242 (53.2) 
ADHD 25 304 (31.5) 3473 (29.6) 
Autism spectrum disorder 20 511 (25.5) 1929 (16.5) 
Developmental delay or unspecified neurodevelopmental disorder 19 002 (23.6) 1007 (8.6) 
Intellectual disability 16 256 (20.2) 1324 (11.3) 
Trauma and stressor related disorders 11 316 (14.1) 1893 (16.1) 
Communication disorder 8634 (10.7) 405 (3.5) 
Feeding and eating disorders 7139 (8.9) 531 (4.5) 
Motor disorder 6311 (7.8) 298 (2.5) 
Bipolar and related disorder 4053 (5.0) 2002 (17.1) 
Specific learning disorder 4153 (5.2) 151 (1.3) 
Obsessive compulsive and related disorders 3217 (4.0) 478 (4.1) 
Neurocognitive disorders 2642 (3.3) 257 (2.2) 
Schizophrenia spectrum and other psychotic disorders 1876 (2.3) 806 (6.9) 
Somatic symptom and related disorders 2116 (2.6) 208 (1.8) 
Sleep or wake disorders 910 (1.1) 126 (1.1) 
Personality disorders 851 (1.1) 453 (3.9) 
Sexual and gender identity disorders 831 (1.0) 118 (1.0) 
Dissociative disorders 58 (0.1) 13 (0.1) 
Substance abuse and related medical illness 7 (0.0) 15 (0.1) 
VariablePHIS, N (%)COMPdata, N (%)
N 80 452 11 724 
Number of CCC   
 1 42 882 (53.3) 8938 (76.2) 
 2 15 696 (19.5) 1640 (14.0) 
 ≥3 21 874 (27.2) 1146 (9.8) 
Type of CCC   
 Neuromuscular 28 412 (35.3) 2323 (19.8) 
 Tech. dependence 25 157 (31.3) 1572 (13.4) 
 Gastrointestinal 24 606 (30.6) 2304 (19.7) 
 Cardiovascular disease 19 004 (23.6) 2946 (25.1) 
 Metabolic 18 694 (23.2) 3617 (30.9) 
 Congenital or genetic 12 927 (16.1) 1316 (11.2) 
 Hematology or immunology 9875 (12.3) 883 (7.5) 
 Renal 7072 (8.8) 595 (5.1) 
 Respiratory 5315 (6.6) 358 (3.1) 
 Malignancy 5576 (6.9) 460 (3.9) 
 Neonatal 1386 (1.7) 74 (0.6) 
 Transplant 628 (0.8) 37 (0.3) 
MBH disorder   
Anxiety disorder 34 172 (42.5) 7006 (59.8) 
Depressive disorders 28 083 (34.9) 6242 (53.2) 
ADHD 25 304 (31.5) 3473 (29.6) 
Autism spectrum disorder 20 511 (25.5) 1929 (16.5) 
Developmental delay or unspecified neurodevelopmental disorder 19 002 (23.6) 1007 (8.6) 
Intellectual disability 16 256 (20.2) 1324 (11.3) 
Trauma and stressor related disorders 11 316 (14.1) 1893 (16.1) 
Communication disorder 8634 (10.7) 405 (3.5) 
Feeding and eating disorders 7139 (8.9) 531 (4.5) 
Motor disorder 6311 (7.8) 298 (2.5) 
Bipolar and related disorder 4053 (5.0) 2002 (17.1) 
Specific learning disorder 4153 (5.2) 151 (1.3) 
Obsessive compulsive and related disorders 3217 (4.0) 478 (4.1) 
Neurocognitive disorders 2642 (3.3) 257 (2.2) 
Schizophrenia spectrum and other psychotic disorders 1876 (2.3) 806 (6.9) 
Somatic symptom and related disorders 2116 (2.6) 208 (1.8) 
Sleep or wake disorders 910 (1.1) 126 (1.1) 
Personality disorders 851 (1.1) 453 (3.9) 
Sexual and gender identity disorders 831 (1.0) 118 (1.0) 
Dissociative disorders 58 (0.1) 13 (0.1) 
Substance abuse and related medical illness 7 (0.0) 15 (0.1) 

Data presented as n (%), unless otherwise noted. ADHD, attention deficit hyperactivity disorder; COMPdata, Illinois Hospital Association COMPdata; PHIS, Pediatric Health Information System.

TABLE 3

Outcomes From the Pediatric Health Information System (PHIS) and Illinois COMPdata Datasets

VariableOverlap CCC and MBH DisorderMBH Disorder OnlyCCC OnlyNo CCC, MBH Disorder
PHIS     
 Number 80 452 255 714 945 194 10 599 570 
 Care on index visit     
  Admitted and/or transferred (primary outcome) 69 605 (86.5) 147 591 (57.7) 491 196 (52.0) 1 008 962 (9.5) 
  Admitted 68 735 (98.8) 124 209 (84.2) 481 264 (98.0) 896 731 (88.9) 
  Transferred 8847 (12.7) 43 453 (29.4) 37 394 (7.6) 139 223 (13.8) 
 Length of stay among admitted patients, days [IQR] 4 [2–8] 3 [1–6] 3 [1–5] 1 [1–2] 
 Diagnostic testing     
  Neuroimaging 17 030 (21.2) 18 621 (7.3) 154 614 (16.4) 468 361 (4.4) 
  CT 12 519 (73.5) 12 748 (68.5) 119 974 (77.6) 417 134 (89.1) 
  MRI 7538 (44.3) 7587 (40.7) 56 489 (36.5) 68 632 (15.6) 
  Laboratory testing 64 566 (80.3) 156 951 (61.4) 622 449 (65.9) 64 566 (80.3) 
 Medication use     
  Psychotherapeutic 44 537 (55.4) 106 726 (41.7) 127 307 (13.5) 249 594 (2.4) 
  Any drug administration 75 255 (93.5) 177 267 (69.3) 781 201 (82.6) 6 586 528 (62.1) 
  Any intravenous drug 62 065 (77.1) 76 354 (29.9) 633 601 (67.0) 2 306 735 (21.8) 
 Cost data, median [IQR]     
 Total costs 10100 [4360–23700] 1920 [579–8200] 2800 [752–10100] 418 [254–806] 
  Laboratory, median cost 474 [176–1140] 120 [0–313] 208 [26.6–629] 0 [0–46.1] 
  Supply, median cost 0 [0–140] 0 [0–0] 0 [0–44.8] 0 [0–0] 
  Imaging, median cost 108 [0–550] 0 [0–0] 93.7 [0–352] 0 [0–88.0] 
  Clinical, median cost 700 [171–2400] 52.1 [0–498] 257 [0–958] 0 [0–75.0] 
  Pharmacy, median cost 458 [87.3–1850] 16.5 [0–141] 85.4 [4.12–685] 1.61 [0–19.0] 
  Other, median cost 6610 [2720–15500] 1180 [393–6290] 1640 [366–6230] 302 [223–465] 
COMPdata 
 Number 11 724 111 950 172 530 5 066 497 
  Admitted and/or transferred, primary outcome 7249 (61.8) 47 908 (42.8) 47 061 (27.3) 161 013 (3.2) 
  Admitted 6546 (90.3) 32 658 (68.2) 43 182 (91.8) 89 043 (55.3) 
  Transferred 1426 (19.7) 17476 (36.5) 5627 (12.0) 74258 (46.1) 
 Length of stay among admitted patients, days [IQR] 4 [2–7] 5 [3–7] 3 [2–6] 2 [1–3] 
 Diagnostic testing     
  Neuroimaging 445 (3.8) 3804 (3.4) 9089 (5.3) 173 491 (3.4) 
  CT 409 (91.9) 3610 (94.9) 8419 (92.6) 169 971 (98.0) 
  MRI 89 (20.0) 359 (9.4) 989 (10.9) 5126 (3.0) 
  Laboratory testing 4018 (34.3) 54 756 (48.9) 88 404 (51.2) 1 978 609 (39.1) 
VariableOverlap CCC and MBH DisorderMBH Disorder OnlyCCC OnlyNo CCC, MBH Disorder
PHIS     
 Number 80 452 255 714 945 194 10 599 570 
 Care on index visit     
  Admitted and/or transferred (primary outcome) 69 605 (86.5) 147 591 (57.7) 491 196 (52.0) 1 008 962 (9.5) 
  Admitted 68 735 (98.8) 124 209 (84.2) 481 264 (98.0) 896 731 (88.9) 
  Transferred 8847 (12.7) 43 453 (29.4) 37 394 (7.6) 139 223 (13.8) 
 Length of stay among admitted patients, days [IQR] 4 [2–8] 3 [1–6] 3 [1–5] 1 [1–2] 
 Diagnostic testing     
  Neuroimaging 17 030 (21.2) 18 621 (7.3) 154 614 (16.4) 468 361 (4.4) 
  CT 12 519 (73.5) 12 748 (68.5) 119 974 (77.6) 417 134 (89.1) 
  MRI 7538 (44.3) 7587 (40.7) 56 489 (36.5) 68 632 (15.6) 
  Laboratory testing 64 566 (80.3) 156 951 (61.4) 622 449 (65.9) 64 566 (80.3) 
 Medication use     
  Psychotherapeutic 44 537 (55.4) 106 726 (41.7) 127 307 (13.5) 249 594 (2.4) 
  Any drug administration 75 255 (93.5) 177 267 (69.3) 781 201 (82.6) 6 586 528 (62.1) 
  Any intravenous drug 62 065 (77.1) 76 354 (29.9) 633 601 (67.0) 2 306 735 (21.8) 
 Cost data, median [IQR]     
 Total costs 10100 [4360–23700] 1920 [579–8200] 2800 [752–10100] 418 [254–806] 
  Laboratory, median cost 474 [176–1140] 120 [0–313] 208 [26.6–629] 0 [0–46.1] 
  Supply, median cost 0 [0–140] 0 [0–0] 0 [0–44.8] 0 [0–0] 
  Imaging, median cost 108 [0–550] 0 [0–0] 93.7 [0–352] 0 [0–88.0] 
  Clinical, median cost 700 [171–2400] 52.1 [0–498] 257 [0–958] 0 [0–75.0] 
  Pharmacy, median cost 458 [87.3–1850] 16.5 [0–141] 85.4 [4.12–685] 1.61 [0–19.0] 
  Other, median cost 6610 [2720–15500] 1180 [393–6290] 1640 [366–6230] 302 [223–465] 
COMPdata 
 Number 11 724 111 950 172 530 5 066 497 
  Admitted and/or transferred, primary outcome 7249 (61.8) 47 908 (42.8) 47 061 (27.3) 161 013 (3.2) 
  Admitted 6546 (90.3) 32 658 (68.2) 43 182 (91.8) 89 043 (55.3) 
  Transferred 1426 (19.7) 17476 (36.5) 5627 (12.0) 74258 (46.1) 
 Length of stay among admitted patients, days [IQR] 4 [2–7] 5 [3–7] 3 [2–6] 2 [1–3] 
 Diagnostic testing     
  Neuroimaging 445 (3.8) 3804 (3.4) 9089 (5.3) 173 491 (3.4) 
  CT 409 (91.9) 3610 (94.9) 8419 (92.6) 169 971 (98.0) 
  MRI 89 (20.0) 359 (9.4) 989 (10.9) 5126 (3.0) 
  Laboratory testing 4018 (34.3) 54 756 (48.9) 88 404 (51.2) 1 978 609 (39.1) 

Data presented as n (%), unless otherwise noted. Numbers in brackets represent interquartile range. Some patients were both admitted and then transferred, so numbers within the composite outcome do not sum to 100%. CCC; complex chronic conditions; CT, computed tomography; IQR, interquartile range; MBH, mental or behavioral health.

From the PHIS dataset, we identified 11 880 930 encounters for patients. Of these, 80 452 (0.7%) had both a CCC and MBH. An MBH diagnosis was present among 7.8% of encounters with a CCC. The most common CCC was neuromuscular (35.3%), followed by technology dependence (31.3%) and gastrointestinal disease (30.6%). The most common type of MBH disorders were anxiety disorders (42.5%), depressive disorders (34.9%), and attention deficit hyperactivity disorder (31.5%).

Overall, 86.5% of encounters with an MBH and CCC had the composite outcome of admission or transfer, which was higher than the proportion admitted or transferred with an MBH alone (57.7%), with a CCC alone (52.0%), or without a CCC nor MBH (9.5%; Table 3). These encounters were almost always admitted to the hospital (98.8%) compared with those with an MBH alone (84.2%). Only 12.7% of patients with CCC and MBH were transferred, compared with 29.4% of patients with an MBH disorder only and 7.6% of patients with CCC only.

Among patients with overlapping MBH and CCC, 16 942 (21.1%) had an MBH primary diagnosis. In multivariable analysis, these patients had 1.41 higher odds of requiring admission or transfer compared when the primary diagnosis was related to an MBH problem alone (95% CI 1.33–1.50).

An analysis of the encounters within the PHIS dataset identified 5 290 300 unique patients between 2016 to 2020. Within this sample, 4 920 241 (93.0%) patients did not have an MBH or CCC, 262 501 (4.9%) had only a CCC, 88 473 (1.7%) had only an MBH diagnosis, and 19 085 (0.4%) had both an MBH and CCC. Patients with overlapping CCC and MBH had similar resource needs, mortality and ICU admission rates over 1 year compared with those with a CCC alone (Supplemental Table 6). For example, patients with overlapping MBH and CCC had 1-year readmission rates (33.9%) that were similar to those with CCC (31.2%), but higher than those with an MBH disorder only (15.8%). A logistic regression model among children with both a CCC and MBH performed on this subset again demonstrated a significant association with having a primary MBH diagnosis and a disposition of admission or transfer (adjusted odds ratio 1.53, 95% CI 1.36–1.72).

A model which adjusted for types of MBH and CCC identified that the association with the composite outcome of admission or transfer was strongest for diagnoses related to mental health history or mental health screening and mood disorders (Supplemental Table 7).

From the COMPdata dataset, 5 362 701 encounters were included. Of these, 11 724 (0.2%) had both a CCC and MBH. Among patients with a CCC, 6.4% had a concomitant MBH diagnosis. The most common types of CCC identified in this subgroup were metabolic (30.9%), cardiovascular (25.1%), and neuromuscular (19.8%). The most common MBH diagnoses were for anxiety (59.8%), depressive disorders (53.2%), and ADHD (29.6%). Patients with a CCC and MBH had a higher need for admission or transfer (61.8%) compared with those with a MBH disorder without a CCC (42.8%) and those with a CCC without MBH disorder (27.3%). Patients with an MBH disorder and CCC who met the outcome measure were more frequently admitted (90.3%) compared with patients with an MBH disorder (68.2%), but not compared with those with a CCC without an MBH disorder (91.8%). Patients with a concomitant MBH disorder and CCC were less frequently transferred (19.7%) compared with those with an MBH disorder alone (36.5%).

Overall, 4289 (36.3%) of patients with a CCC and MBH had an MBH primary diagnosis. We identified a multivariable odds of 3.47 (95% CI 3.13–3.84) of requiring admission or transfer when the primary diagnosis was for an MBH disorder. In a sensitivity analysis, a model which adjusted for types of MBH and CCC identified that the association with the composite outcome of admission or transfer was again strongest for mood disorders, ADHD, and diagnoses related to mental health history or mental health screening (Supplemental Table 8).

In both datasets, encounters for patients with an MBH, CCC, and both an MBH and CCC demonstrated an increase over time, superimposed over cyclical seasonal trends (Fig 1). All groups demonstrated a decrease during the second quarter of 2020, followed by a subsequent rise.

FIGURE 1

MBH, CCC, and both MBH and CCC yearly encounters between 2016 and 2021.

FIGURE 1

MBH, CCC, and both MBH and CCC yearly encounters between 2016 and 2021.

Close modal

We identified distinct patterns in the ED distribution of CCC and MBH, both within pediatric hospitals and from a statewide sample of EDs. MBH disorders occurred in ∼ 5% of children in the ED with a CCC. Among this segment, an MBH disorder was the primary diagnosis among a quarter to one third of patients. Children with concomitant CCC and MBH disorder had a greater need for admission or transfer during their ED encounter relative to other subgroups of patients.

MBH considerations are an important challenge in the care of medically complex children. In a study evaluating trends and resource use for children with psychiatric emergencies in children’s hospitals, patients with greater medical complexity had a higher proportion of also having a concomitant psychiatric condition, which corroborates with our analysis.25  The MBH diagnoses encountered by children with CCC may require differing approaches compared with those without medical complexity, particularly as a high proportion of patients with medical complexity (approximately 70% in one study) have developmental disabilities.26  The care of these children likely requires dedicated mental health expertise, including the availability of mental health services which can support the needs of children who use nonverbal forms of communication, facilities which can simultaneously handle medical and behavioral issues, and use of pharmacologic aids for the deescalation of agitation and other behavioral emergencies. This may explain the higher association with admission or transfer among those with a primary diagnosis of a mood disorder and CCC, which includes depressive and bipolar disorders.

Our findings contribute important information on the MBH needs of children with medical complexity. Data from the National Survey of Children with Special Health Care Needs suggest that half of children with medical complexity had a mental health condition.26  An evaluation of the National Health Interview Survey Disability Supplements reported that approximately 14% of children with disabilities receive mental health services.16  Our results corroborate the high demand for mental health services required by children with CCCs and demonstrates the high requirement for admission or transfer in this subgroup relative to patients with CCC not having MBH disorders.

Our findings fit into the context of literature demonstrative of the challenges of taking care of children with medical complexity within the healthcare system, where prior work has reported the unique challenges faced by parents and caregivers.11,27  Children, with or without CCCs, face challenges in obtaining psychiatric care for multifactorial reasons, including limited access to child psychiatrists and a shortage of inpatient beds.28  These challenges are likely compounded in medically complex children who have a concomitant MBH diagnosis. A longer term stay in the ED, termed “boarding,” can lead to issues of overcrowding, and the ED is poorly suited toward delivering psychiatric care. Alternatively, transfer of medically complex children to a distant place of care may limit the ability of families to participate in the care of the child.

Our comparison of children’s hospital data to statewide data also highlights important differences in decision making and resources at these 2 respective sites of care. Both datasets identified a high rate of admission or transfer among patients with overlapping CCC and MBH conditions. Among those meeting this outcome measure, admission to freestanding children’s hospitals was comparatively higher compared with those noted from the COMPdata hospitals. These data suggest that children’s hospitals almost uniformly admit patients with MBH in children with concomitant medical complexity. However, some pediatric facilities may not be licensed for psychiatric care and may at times have fewer mental health resources compared with psychiatric institutions. In contrast, the COMPdata patients with these disorders had lower acuity and had a higher rate of transfer, suggesting that a greater proportion of these facilities may be inadequately suited toward delivering care to children with CCCs.

Further work is needed to delineate best-practice guidelines for these children. The high proportion of children who are admitted or transferred in this subgroup suggests a need for improved outpatient care targeted toward optimization of mental health needs, caregiving needs, and family health. Important topics relevant to children with MBH disorders and CCCs identified in this study by the National Research Agenda on Health Systems for Children and Youth With Special Health Care Needs include those related to caregiving, family health, and principles of care (which includes offering medical home services, integration with community entities and resources, and facilitation of high-quality care transitions).29  Hospital priorities include targeted questions to caregivers to identify optimal supports, the design of facilities to reduce unnecessary environmental stressors, and the consideration of organic causes for behavioral changes, which may be of greater relevance for medically complex children. One recent study using a multidisciplinary Delphi panel, for example, identified key quality metrics for the management of pediatric agitation, with a special emphasis on the management of children with developmental disorders.30 

Our findings are subject to limitations. This study was performed using administrative data that relied on diagnosis codes to identify CCC and an MBH disorders. As EDs may undercode some diagnoses, we suspect that findings may underestimate the frequency of these conditions among the study populations. We were unable to account for repeat encounters from the same patient in the COMPdata dataset. We were unable to ascertain relevant factors in the care of patients with MBH and CCC, such as ED or inpatient boarding, as we do not have reasons for admission or length of stay data in the ED in more granular units of hours. Although we used the primary diagnosis code to identify the primary reason for the encounter, chief complaint data are lacking in both datasets. Despite these limitations, the findings from this study demonstrate the unique healthcare needs of children with concomitant CCC and MBH disorders.

MBH disorders occur in ∼ 5% of encounters with a CCC who present to the ED. These patients have a higher requirement for admission or transfer relative to other patients. The presence of an MBH disorder as a primary diagnosis for these patients is associated with a need for admission or transfer. Further research is required to understand the specific types of MBH and identify best practice guidelines among this vulnerable group of children.

FUNDING: Dr Ramgopal is funded by PEDSnet (Department of Pediatrics, Ann and Robert H Lurie Children’s Hospital, Chicago, IL). Dr Foster’s time was supported under 1K23HL149829-01A1 for research related to care of children with medical complexity. Dr Kan’s time was supported under 1K23HL157615-01A1. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

CONFLICT OF INTEREST DISCLOSURES: Dr Foster receives compensation for medical record consultation and/or expert witness testimony. The authors have indicated they have no conflicts of interest to disclose.

Dr Ramgopal contributed to conceptualization and design of the study, data analysis, and drafting of the manuscript; Drs Goodman, Kan, and Foster contributed to conceptualization and design of the study, methodology, and editing of the manuscript for intellectually important content; and all authors gave final approval for the version to be published and agree to be accountable for all aspects of the work.

1.
Cutler
GJ
,
Rodean
J
,
Zima
BT
, et al
.
Trends in pediatric emergency department visits for mental health conditions and disposition by presence of a psychiatric unit
.
Acad Pediatr
.
2019
;
19
(
8
):
948
955
2.
Leff
RA
,
Setzer
E
,
Cicero
MX
,
Auerbach
M
.
Changes in pediatric emergency department visits for mental health during the COVID-19 pandemic: a cross-sectional study
.
Clin Child Psychol Psychiatry
.
2021
;
26
(
1
):
33
38
3.
Ramgopal
S
,
Pelletier
JH
,
Rakkar
J
,
Horvat
CM
.
Forecast modeling to identify changes in pediatric emergency department utilization during the COVID-19 pandemic
.
Am J Emerg Med
.
2021
;
49
:
142
147
4.
Hu
N
,
Nassar
N
,
Shrapnel
J
, et al
.
The impact of the COVID-19 pandemic on paediatric health service use within one year after the first pandemic outbreak in New South Wales Australia - a time series analysis
.
Lancet Reg Health West Pac
.
2022
;
19
:
100311
5.
Burstein
B
,
Agostino
H
,
Greenfield
B
.
Suicidal attempts and ideation among children and adolescents in US emergency departments, 2007-2015
.
JAMA Pediatr
.
2019
;
173
(
6
):
598
600
6.
Burns
KH
,
Casey
PH
,
Lyle
RE
,
Bird
TM
,
Fussell
JJ
,
Robbins
JM
.
Increasing prevalence of medically complex children in US hospitals
.
Pediatrics
.
2010
;
126
(
4
):
638
646
7.
Akenroye
AT
,
Thurm
CW
,
Neuman
MI
, et al
.
Prevalence and predictors of return visits to pediatric emergency departments
.
J Hosp Med
.
2014
;
9
(
12
):
779
787
8.
Berry
JG
,
Hall
M
,
Hall
DE
, et al
.
Inpatient growth and resource use in 28 children’s hospitals: a longitudinal, multi-institutional study
.
JAMA Pediatr
.
2013
;
167
(
2
):
170
177
9.
Peltz
A
,
Samuels-Kalow
ME
,
Rodean
J
, et al
.
Characteristics of children enrolled in medicaid with high-frequency emergency department use
.
Pediatrics
.
2017
;
140
(
3
):
e20170962
10.
Kane
JM
,
Hall
M
,
Cecil
C
, et al
.
Resources and costs associated with repeated admissions to PICUs
.
Crit Care Explor
.
2021
;
3
(
2
):
e0347
11.
Kuo
DZ
,
Cohen
E
,
Agrawal
R
,
Berry
JG
,
Casey
PH
.
A national profile of caregiver challenges among more medically complex children with special health care needs
.
Arch Pediatr Adolesc Med
.
2011
;
165
(
11
):
1020
1026
12.
Cohen
E
,
Berry
JG
,
Sanders
L
,
Schor
EL
,
Wise
PH
.
Status complexicus? The emergence of pediatric complex care
.
Pediatrics
.
2018
;
141
(
Suppl 3
):
S202
S211
13.
Cohen
E
,
Berry
JG
,
Camacho
X
,
Anderson
G
,
Wodchis
W
,
Guttmann
A
.
Patterns and costs of health care use of children with medical complexity
.
Pediatrics
.
2012
;
130
(
6
):
e1463
e1470
14.
Kuo
DZ
,
Melguizo-Castro
M
,
Goudie
A
,
Nick
TG
,
Robbins
JM
,
Casey
PH
.
Variation in child health care utilization by medical complexity
.
Matern Child Health J
.
2015
;
19
(
1
):
40
48
15.
Coller
RJ
,
Berry
JG
,
Kuo
DZ
, et al
.
Health system research priorities for children and youth with special health care needs
.
Pediatrics
.
2020
;
145
(
3
):
e20190673
16.
Witt
WP
,
Kasper
JD
,
Riley
AW
.
Mental health services use among school-aged children with disabilities: the role of sociodemographics, functional limitations, family burdens, and care coordination
.
Health Serv Res
.
2003
;
38
(
6 pt 1
):
1441
1466
17.
Illinois Department of Public Heath
.
Illinois hospitals
.
Available at: www.idph.state.il.us/tfhpr/materials/Map handout.pdf. Accessed January 17, 2022
18.
Hudgins
JD
,
Monuteaux
MC
,
Bourgeois
FT
, et al
.
Complexity and severity of pediatric patients treated at United States emergency departments
.
J Pediatr
.
2017
;
186
:
145
149.e1
19.
Feudtner
C
,
Feinstein
JA
,
Zhong
W
,
Hall
M
,
Dai
D
.
Pediatric complex chronic conditions classification system version 2: updated for ICD-10 and complex medical technology dependence and transplantation
.
BMC Pediatr
.
2014
;
14
:
199
20.
Simon
TD
,
Haaland
W
,
Hawley
K
,
Lambka
K
,
Mangione-Smith
R
.
Development and validation of the pediatric medical complexity algorithm (PMCA) version 3.0
.
Acad Pediatr
.
2018
;
18
(
5
):
577
580
21.
Zima
BT
,
Gay
JC
,
Rodean
J
, et al
.
Classification system for international classification of diseases, ninth revision, clinical modification and tenth revision pediatric mental health disorders
.
JAMA Pediatr
.
2020
;
174
(
6
):
620
622
22.
Williams
K
,
Thomson
D
,
Seto
I
, et al
.
Standard 6: age groups for pediatric trials
.
Pediatrics
.
2012
;
129
(
Suppl 3
):
S153
S160
23.
Marrast
L
,
Himmelstein
DU
,
Woolhandler
S
.
Racial and ethnic disparities in mental health care for children and young adults: a national study
.
Int J Health Serv
.
2016
;
46
(
4
):
810
824
24.
Kuo
DZ
,
Goudie
A
,
Cohen
E
, et al
.
Inequities in health care needs for children with medical complexity
.
Health Aff (Millwood)
.
2014
;
33
(
12
):
2190
2198
25.
Zima
BT
,
Rodean
J
,
Hall
M
,
Bardach
NS
,
Coker
TR
,
Berry
JG
.
Psychiatric disorders and trends in resource use in pediatric hospitals
.
Pediatrics
.
2016
;
138
(
5
):
e20160909
26.
Mooney-Doyle
K
,
Lindley
LC
.
Family and child characteristics associated with caregiver challenges for medically complex children
.
Fam Community Health
.
2020
;
43
(
1
):
74
81
27.
Golden
SL
,
Nageswaran
S
.
Caregiver voices: coordinating care for children with complex chronic conditions
.
Clin Pediatr (Phila)
.
2012
;
51
(
8
):
723
729
28.
Thomas
CR
,
Holzer
CE
III
.
The continuing shortage of child and adolescent psychiatrists
.
J Am Acad Child Adolesc Psychiatry
.
2006
;
45
(
9
):
1023
1031
29.
Stille
CJ
,
Coller
RJ
,
Shelton
C
,
Wells
N
,
Desmarais
A
,
Berry
JG
.
National research agenda on health systems for children and youth with special health care needs
.
Acad Pediatr
.
2022
;
22
(
2S
):
S1
S6
30.
Hoffmann
JA
,
Pergjika
A
,
Konicek
CE
,
Reynolds
SL
.
Pharmacologic management of acute agitation in youth in the emergency department
.
Pediatr Emerg Care
.
2021
;
37
(
8
):
417
422

Supplementary data